Fetal Cardiac Disorder Clinical Trial
Official title:
Evaluation of Fetal Cardiac Function With aCMQ-STRAIN: Normality Curve and Comparison to Fetus With Cardiac Disfunction Risk Factors
To assess whether the aCQM-Strain ultrasound method allows a good analysis of fetal cardiac function. Establish normality parameters and compare it with fetuses with risk factors of cardiac dysfunction.
National unicentric observational study of follow-up study of a cohort. It has been decided
to conduct a study of consecutive cases, including all patients who meet the inclusion
criteria during the time of the study.
Until now, there has not been an easy and convenient method to determine fetal cardiac
function. Recently a new Software (Automated Cardiac Motion Quantification aCMQ) has been
developed, and it seems that allows an easier analysis of this one.
This study aims to analyze fetal heart function with the Strain method in healthy patients
and then compare it with fetuses with risk factors for cardiac dysfunction.
Initially, healthy pregnant patients who agree to participate in the study will be cited,
after signing the informed consent, in order to evaluate the normal fetal cardiac function
and see how it is modified in the different weeks of gestation.
To do this, a fetal echocardiography will be performed by the investigators at week 24, 28,
32 and 36 of pregnancy, using the aCMQ-Strain method.
Once the investigators have established normality curves, fetuses with risk factors for
cardiac dysfunction of women who agree to participate in the study will be analyzed. For this
purpose, a fetal echocardiography at week 24, 28, 32 and 36 of gestation, using the
aCMQ-Strain method will be performed.
All tests will be carried out in the same study center and will be carried out by independent
scouts.The data obtained in each test will be collected in an anonymized database for further
study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05066399 -
Fetal Cardiac Magnetic Resonance in Detection of CHD
|
||
| Not yet recruiting |
NCT05877131 -
Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions
|
Phase 4 | |
| Completed |
NCT05737043 -
Modified Myocardial Performance Index and Epicardial Thickness in Cases With Idiopathic Polyhydramnios
|
N/A | |
| Recruiting |
NCT03775954 -
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
|
||
| Recruiting |
NCT05386173 -
Effect of Fetal Aortic Valvuloplasty on Outcomes
|
||
| Recruiting |
NCT05172336 -
Fetal Cardiac Remodeling in Singleton Pregnancies Conceived by Assisted Reproductive Technology (Biopsied and Non-Biopsied ICSI) Versus Those Normally Conceived
|